CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-02 | CARDOZA GEORGE President, Pharma Services | Grant or award · Common Stock | +48,768 | $28.33 | $1.4M | 48,768 |
| 2020-03-02 | SHOVLIN ROBERT J. President, Clinical Services | Grant or award | +8,736 | 153,566 | ||
| 2020-03-02 | SHOVLIN ROBERT J. President, Clinical Services | Grant or award · Common Stock | +56,271 | $28.33 | $1.6M | 56,271 |
| 2020-03-02 | Weiss Lawrence Martin Chief Medical Officer | Grant or award | +5,824 | 11,717 | ||
| 2020-03-02 | Weiss Lawrence Martin Chief Medical Officer | Grant or award · Common Stock | +37,514 | $28.33 | $1.1M | 37,514 |
| 2020-03-02 | VAN OORT DOUGLAS M Chairman and CEO | Grant or award | +34,945 | 2,316,073 | ||
| 2020-03-02 | VAN OORT DOUGLAS M Chairman and CEO | Grant or award · Common Stock | +225,084 | $28.33 | $6.4M | 225,084 |
| 2020-03-02 | McKenzie Kathryn B Chief Financial Officer | Grant or award | +5,824 | 7,929 | ||
| 2020-03-02 | McKenzie Kathryn B Chief Financial Officer | Grant or award · Common Stock | +37,514 | $28.33 | $1.1M | 37,514 |
| 2020-03-01 | Bonello William President, Informatics | Shares withheld for taxes | −499 | 6,236 | ||
| 2020-03-01 | BALLIET JENNIFER VP and Chief Culture Officer | Shares withheld for taxes | −212 | 22,650 | ||
| 2020-03-01 | SHOVLIN ROBERT J. President, Clinical Services | Shares withheld for taxes | −810 | 144,830 | ||
| 2020-03-01 | VAN OORT DOUGLAS M Chairman and CEO | Shares withheld for taxes | −2,353 | 2,281,128 | ||
| 2020-03-01 | McKenzie Kathryn B Chief Financial Officer | Shares withheld for taxes | −168 | 2,105 | ||
| 2019-12-30 | JONES STEVEN C Director | Exercise or conversion | +100,000 | $4.78 | $478K | 1,625,000 |
| 2019-12-30 | JONES STEVEN C Director | Other disposition · Stock Option (Right to Buy) | −225,000 | 0 | ||
| 2019-12-30 | JONES STEVEN C Director | Other acquisition · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2019-12-30 | JONES STEVEN C Director | Exercise or conversion · Stock Option (Right to Buy) | −100,000 | 125,000 | ||
| 2019-12-30 | JONES STEVEN C Director | Other disposition · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2019-12-30 | JONES STEVEN C Director | Other acquisition · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 34 of 51 · 1,005 trades